By Drs. David Niesel and Norbert Herzog

An international trial was recently published revealing the outcomes for 145 patients with relapsing-remitting multiple sclerosis who received blood stem cell transplantation. Excitingly, these stem cell transplants were associated with substantial improvements in neurological symptoms and other clinical outcomes of MS. While these are preliminary findings they are nonetheless exciting. MS is a disease in which a person’s own immune system attacks the myelin sheath that covers nerves. This reduces the ability of nerves in your brain to efficiently communicate with your muscles. Myelin is a wrapping made of lipids or fats and proteins that serve to insulate and protect nerves much like the plastic covering of electrical wires. Myelin also serves to g…

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Source link


Please enter your comment!
Please enter your name here

Enter Captcha Here : *

Reload Image